Denali Therapeutics (DNLI) Net Margin (QoQ) (2018 - 2023)
Denali Therapeutics (DNLI) Net Margin (QoQ) (2018 - 2023) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Denali Therapeutics | 4.37 Bn | 4.37 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -790,394.00 |
| Jun 30, 2023 | 38,328.00 |
| Mar 31, 2023 | 66,585.00 |
| Dec 31, 2022 | 207,393.00 |
| Sep 30, 2022 | -294,868.00 |
| Jun 30, 2022 | 5,198.00 |
| Mar 31, 2022 | -932.00 |
| Dec 31, 2021 | 144,584.00 |
| Sep 30, 2021 | -119,592.00 |
| Jun 30, 2021 | 47,953.00 |
| Mar 31, 2021 | -96,143.00 |
| Dec 31, 2020 | 69,754.00 |
| Sep 30, 2020 | 39,091.00 |
| Jun 30, 2020 | 10.82 Mn |
| Mar 31, 2020 | -10.56 Mn |
| Dec 31, 2019 | -258,560.00 |
| Sep 30, 2019 | 36,036.00 |
| Jun 30, 2019 | -49,627.00 |
| Mar 31, 2019 | -98,897.00 |
| Dec 31, 2018 | 302,161.00 |